A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.

A total of 458 eligible patients, from 21 centres, with microscopically confirmed SCLC were allocated at random to three chemotherapy regimens, each given at 3-week intervals. In two regimens, etoposide, cyclophosphamide, methotrexate and vincristine were given for a total of either three courses (E...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Bleehen, N. M., Girling, D. J., Machin, D., Stephens, R. J.
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 1993
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968653/
https://ncbi.nlm.nih.gov/pubmed/7505104
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים